Lung Decortication With Argon Plasma Energy for the Treatment of Chronic Pleural Empyema

2021 ◽  
pp. 155698452110111
Author(s):  
Savvas Lampridis ◽  
Sofoklis Mitsos ◽  
David R. Lawrence ◽  
Nikolaos Panagiotopoulos
Keyword(s):  
Energy Source ◽  
Surgical Management ◽  
Argon Plasma ◽  
Pleural Empyema ◽  
Controlled Trials ◽  
Air Leak ◽  
Pulmonary Tissue ◽  
Pure Argon ◽  
Plasma Energy ◽  
Minimal Depth

Lung decortication for the treatment of chronic pleural empyema remains a technically challenging procedure that is associated with bleeding and air leak. The recent advent of pure argon plasma has provided thoracic surgeons with an electrically neutral energy source for dissection and coagulation of pulmonary tissue with minimal depth of necrosis. In this article, we describe the technique of lung decortication with argon plasma energy (PlasmaJet, Plasma Surgical, Roswell, GA, USA) for the treatment of chronic pleural empyema. With appropriate application, the PlasmaJet can facilitate the removal of fibrous cortex with satisfactory hemostasis and aerostasis. Argon plasma energy can potentially be a useful adjunct in lung decortication. Controlled trials are needed to determine its role in the surgical management of advanced pleural empyema.

Diagnostics and modeling in a pure argon plasma - Energy balance study

1997 ◽  
Author(s):  
U. Kelkar ◽  
M. Gordon ◽  
L. Roe ◽  
Y. Li ◽  
U. Kelkar ◽  
...  
Keyword(s):  
Energy Balance ◽  
Argon Plasma ◽  
Balance Study ◽  
Pure Argon ◽  
Plasma Energy

Diagnostics and modeling in a pure argon plasma: Energy balance study

1999 ◽  
Vol 17 (1) ◽  
pp. 125-132 ◽  
Author(s):  
U. M. Kelkar ◽  
M. H. Gordon ◽  
L. A. Roe ◽  
Y. Li
Keyword(s):  
Energy Balance ◽  
Argon Plasma ◽  
Balance Study ◽  
Pure Argon ◽  
Plasma Energy

scholarly journals A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation

Plasma ◽  
2018 ◽  
Vol 1 (1) ◽  
pp. 189-200 ◽  
Author(s):  
Lawan Ly ◽  
Sterlyn Jones ◽  
Alexey Shashurin ◽  
Taisen Zhuang ◽  
Warren Rowe ◽  
...  
Keyword(s):  
Cold Plasma ◽  
Ex Vivo ◽  
Argon Plasma Coagulation ◽  
Tumor Resection ◽  
Argon Plasma ◽  
Plasma Jet ◽  
Atmospheric Plasma ◽  
Tissue Temperature ◽  
Plasma Coagulation ◽  
Plasma Energy

The use of plasma energy has expanded in surgery and medicine. Tumor resection in surgery and endoscopy has incorporated the use of a plasma scalpel or catheter for over four decades. A new plasma energy has expanded the tools in surgery: Cold Atmospheric Plasma (CAP). A cold plasma generator and handpiece are required to deliver the CAP energy. The authors evaluated a new Cold Plasma Jet System. The Cold Plasma Jet System consists of a USMI Cold Plasma Conversion Unit, Canady Helios Cold Plasma® Scalpel, and the Canady Plasma® Scalpel in Hybrid and Argon Plasma Coagulation (APC) modes. This plasma surgical system is designed to remove the target tumor with minimal blood loss and subsequently spray the local area with cold plasma. In this study, various operational parameters of the Canady Plasma® Scalpels were tested on ex vivo normal porcine liver tissue. These conditions included various gas flow rates (1.0, 3.0, 5.0 L/min), powers (20, 40, 60 P), and treatment durations (30, 60, 90, 120 s) with argon and helium gases. Plasma length, tissue temperature changes, and depth and eschar injury magnitude measurements resulting from treatment were taken into consideration in the comparison of the scalpels. The authors report that a new cold plasma jet technology does not produce any thermal damage to normal tissue.

Prognostic factors influencing the outcome of empyema surgical management: prospective study in a Moroccan university center.

2021 ◽  
Vol 1 (1) ◽  
Author(s):  
Sara Hafidi ◽  
Souheil Boubia ◽  
Abdellah Fatene ◽  
Najat Id El Haj ◽  
Mohammed Ridai
Keyword(s):  
Surgical Treatment ◽  
Surgical Management ◽  
Public Health Problem ◽  
Pleural Empyema ◽  
Chronic Alcoholism ◽  
University Teaching ◽  
University Center ◽  
Post Traumatic ◽  
Surgery Department ◽  
Delay Of Diagnosis

Background: Pleural empyema is a public health problem, and is the most frequent complication of pleural infection with significant morbidity and mortality worldwide. Our study aims to highlight the management of pleural empyema and evaluate its prognosis factors involved especially in surgical treatment. Patients and Methods: A prospective analysis of 53 patients who underwent surgical treatment of pleural empyema, from January 2015 to December 2019 at the thoracic surgery department in a tertiary referral university teaching hospital. Our study included patients who required surgical treatment for pleural empyema and were excluded patients with destroyed lungs associated with pyothorax. Results: The mean age of patients was 39.24±15.89 years and 79,24% of them were males. In 85.7% of the cases, the etiology was undetermined in 34%, parapneumonic in 1.9%, of tuberculosis in 54.71%, post-traumatic in 11, 3%, postoperative in 7.5% and iatrogenic in 1.9%. 45 patients were treated with broad-spectrum antibiotics therapy adapted after antibiogram 14.38±21.76 days before the operation. A complete debridement and decortications were performed by VATS in 28 and by PLT in 22 patients. No major complications occurred. At a mean term follow-up of 20 months (3months—3 years); all patients were alive with no recurrence. The analysis of the results showed 4 factors of poor prognosis: delay of diagnosis and surgery (P = 0.02), chronic alcoholism (P = 0.034), preoperative ventilation disorder/COPD (P = 0.04) and active tuberculosis (P= 0, 05). Conclusion: The success of surgical management of pleural empyema depends on several factors, which predict the prognosis, but can be prevented.

Invasive pulmonary aspergillosis in a child with acute myeloid leukaemia: pharmacotherapy and surgical management

Oncoreview ◽  
2016 ◽  
Vol 6 (4) ◽  
pp. 0-0
Author(s):  
Jan Styczyński
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Surgical Management ◽  
Lung Tissue ◽  
Invasive Pulmonary Aspergillosis ◽  
Invasive Fungal Disease ◽  
Pulmonary Tissue ◽  
Hematopoietic Stem ◽  
Good Penetration ◽  
Acute Myeloid

This paper reports on diagnostic and therapeutic management of pulmonary invasive fungal disease (IFD) in a child with relapsed acute myeloid leukaemia, undergoing chemotherapy followed by hematopoietic stem cell transplantation. Surgical management with resection of the involved lung tissue was based on the location of fungal infiltrates close to large circulatory vessels. After examination of resected pulmonary tissue, a diagnosis of proven IFD was done. This case report is an example that aspergillosis is usually the cause for pulmonary IFD. Pharmacotherapy of pulmonary IFD should be based on compounds with good penetration to lung tissue: amphotericin B lipid form or voriconazole.

scholarly journals EACTS expert consensus statement for surgical management of pleural empyema

2015 ◽  
Vol 48 (5) ◽  
pp. 642-653 ◽  
Author(s):  
Marco Scarci ◽  
Udo Abah ◽  
Piergiorgio Solli ◽  
Aravinda Page ◽  
David Waller ◽  
...  
Keyword(s):  
Surgical Management ◽  
Consensus Statement ◽  
Pleural Empyema ◽  
Expert Consensus
Sign in / Sign up

Export Citation Format

Share Document